M. Ghielmini and E. Zucca, How I treat mantle cell lymphoma, Blood, vol.114, issue.8, pp.1469-1476, 2009.
DOI : 10.1182/blood-2009-02-179739

A. Goy and B. Kahl, Mantle cell lymphoma: The promise of new treatment options, Critical Reviews in Oncology/Hematology, vol.80, issue.1, pp.69-86, 2011.
DOI : 10.1016/j.critrevonc.2010.09.003

J. Leonard, M. Williams, A. Goy, S. Grant, and M. Pfreundschuh, Mantle Cell Lymphoma: Biological Insights and Treatment Advances, Clinical Lymphoma and Myeloma, vol.9, issue.4, pp.267-277, 2009.
DOI : 10.3816/CLM.2009.n.055

S. Michiels, S. Koscielny, and C. Hill, Prediction of cancer outcome with microarrays: a multiple random validation strategy, The Lancet, vol.365, issue.9458, pp.488-492, 2005.
DOI : 10.1016/S0140-6736(05)17866-0

C. Gomez-roca, L. Lacroix, C. Massard, D. Baere, T. Deschamps et al., Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety, Annals of Oncology, vol.23, issue.5, p.21917737, 2012.
DOI : 10.1093/annonc/mdr383

B. Hogan, Bone morphogenetic proteins in development, Current Opinion in Genetics & Development, vol.6, issue.4, pp.432-438, 1996.
DOI : 10.1016/S0959-437X(96)80064-5

K. Miyazono, S. Maeda, and T. Imamura, BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talk, Cytokine & Growth Factor Reviews, vol.16, issue.3, 2005.
DOI : 10.1016/j.cytogfr.2005.01.009

K. Tamaki, S. Souchelnytskyi, S. Itoh, A. Nakao, and K. Sampath, Intracellular signaling of osteogenic protein-1 through Smad5 activation, Journal of Cellular Physiology, vol.7, issue.2, pp.355-36310, 1998.
DOI : 10.1002/(SICI)1097-4652(199811)177:2<355::AID-JCP17>3.0.CO;2-8

A. Zwijsen, K. Verschueren, and D. Huylebroeck, New intracellular components of bone morphogenetic protein/Smad signaling cascades, FEBS Letters, vol.273, issue.1, pp.133-139, 2003.
DOI : 10.1016/S0014-5793(03)00566-0

S. Beck and J. Carethers, BMP suppresses PTEN expression via RAS/ERK signaling, Cancer Biology & Therapy, vol.6, issue.8, pp.1313-1317, 2007.
DOI : 10.4161/cbt.6.8.4507

M. Hu, D. Wasserman, S. Hartwig, and N. Rosenblum, p38MAPK Acts in the BMP7-dependent Stimulatory Pathway during Epithelial Cell Morphogenesis and Is Regulated by Smad1, Journal of Biological Chemistry, vol.279, issue.13, pp.12051-12059, 2004.
DOI : 10.1074/jbc.M310526200

S. Yang, M. Lim, L. Pham, S. Kendall, and A. Reddi, Bone Morphogenetic Protein 7 Protects Prostate Cancer Cells from Stress-Induced Apoptosis via Both Smad and c-Jun NH2-Terminal Kinase Pathways, Cancer Research, vol.66, issue.8, pp.4285-4290, 2006.
DOI : 10.1158/0008-5472.CAN-05-4456
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.487.9112

E. Alarmo, J. Pärssinen, J. Ketolainen, K. Savinainen, and R. Karhu, BMP7 influences proliferation, migration, and invasion of breast cancer cells, Cancer Letters, vol.275, issue.1, pp.35-43, 2009.
DOI : 10.1016/j.canlet.2008.09.028

M. Aoki, S. Ishigami, Y. Uenosono, T. Arigami, and Y. Uchikado, Expression of BMP-7 in human gastric cancer and its clinical significance, British Journal of Cancer, vol.18, issue.4, p.21224856, 2011.
DOI : 10.1016/S0014-5793(03)00566-0

K. Motoyama, F. Tanaka, Y. Kosaka, K. Mimori, and H. Uetake, Clinical Significance of BMP7 in Human Colorectal Cancer, Annals of Surgical Oncology, vol.291, issue.5, pp.1530-153710, 2008.
DOI : 10.1245/s10434-007-9746-4

T. Rothhammer, I. Poser, F. Soncin, F. Bataille, and M. Moser, Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration, Cancer Res, vol.65, pp.448-456, 2005.

J. Sunde, H. Donninger, K. Wu, M. Johnson, and R. Pestell, Expression Profiling Identifies Altered Expression of Genes That Contribute to the Inhibition of Transforming Growth Factor-?? Signaling in Ovarian Cancer, Cancer Research, vol.66, issue.17, pp.8404-8412, 2006.
DOI : 10.1158/0008-5472.CAN-06-0683

S. Yang, L. Pham, C. Liao, B. Frenkel, and A. Reddi, A Novel Bone Morphogenetic Protein Signaling in Heterotypic Cell Interactions in Prostate Cancer, Cancer Research, vol.68, issue.1, pp.198-205, 2008.
DOI : 10.1158/0008-5472.CAN-07-5074

K. Huse, M. Bakkebø, S. Wälchli, M. Oksvold, and V. Hilden, Role of Smad Proteins in Resistance to BMP-Induced Growth Inhibition in B-Cell Lymphoma, PLoS ONE, vol.7, issue.10, p.23049692, 2012.
DOI : 10.1371/journal.pone.0046117.s014

D. Grcevi?, R. Kusec, N. Kovaci?, A. Luki?, and I. Luki?, Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes, Leukemia Research, vol.34, issue.6, pp.742-751, 2010.
DOI : 10.1016/j.leukres.2009.10.016

K. Huse, M. Bakkebø, M. Oksvold, L. Forfang, and V. Hilden, Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6, p.7, 2011.

T. Rothhammer, P. Wild, S. Meyer, F. Bataille, and A. Pauer, Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma1, Cancer Biomarkers, vol.3, issue.2, pp.111-117, 2007.
DOI : 10.3233/CBM-2007-3205

K. Kron, V. Pethe, L. Briollais, B. Sadikovic, and H. Ozcelik, Discovery of Novel Hypermethylated Genes in Prostate Cancer Using Genomic CpG Island Microarrays, PLoS ONE, vol.59, issue.3, 2009.
DOI : 10.1371/journal.pone.0004830.t003

S. Yamashita, Y. Tsujino, K. Moriguchi, M. Tatematsu, and T. Ushijima, Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray, Cancer Science, vol.275, issue.1, 2006.
DOI : 10.1158/0008-5472.CAN-05-0289